Who invested in Solstice Oncology?
Solstice Oncology's investors include Canaan, RA Capital Management and Forbion Capital Partners.

United States · Series A startup
Funding summaryUpdated 26 Oct 2026
$225Mraised across 1 round since 2026, from 1 source
Solstice Oncology's investors include Canaan, RA Capital Management and Forbion Capital Partners.
Solstice Oncology has raised $225M across 1 round since 2026.
Solstice Oncology's most recent round was a Series A of $225M in Sept 2026.
Its most recent round, $225M in Sept 2026, is also its largest on record.
Solstice Oncology's first round on record, in Sept 2026, was backed by Canaan, RA Capital Management and Forbion Capital Partners.
Solstice Oncology's latest named round is a Series A, in Sept 2026.
Solstice Oncology is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.